A startup backed by $80 million from investors is striking deals with a range of drug companies in its bid to lead the next wave of mental-health treatments.
Atai Life Sciences Is Assembling a Mental-Health Drug Platform
September 19, 2019
Articles
7:21 pm
JOIN OUR MAILING LIST
Sign up to receive the latest news on atai.
Email